What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome Study guides, Class notes & Summaries

Looking for the best study guides, study notes and summaries about What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome? On this page you'll find 226 study documents about What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome.

Page 2 out of 226 results

Sort by

ANCC Review Questions and Answers 2022/2023 (PMHNP IQ) ANCC Review Questions and Answers 2022/2023 (PMHNP IQ)
  • ANCC Review Questions and Answers 2022/2023 (PMHNP IQ)

  • Exam (elaborations) • 8 pages • 2022
  • ANCC Review Questions and Answers 2022/2023 (PMHNP IQ)
    (3)
  • $11.99
  • 4x sold
  • + learn more
ANCC REVIEW EXAM 2024 WITH 100% CORRECT ANSWERS
  • ANCC REVIEW EXAM 2024 WITH 100% CORRECT ANSWERS

  • Exam (elaborations) • 5 pages • 2024
  • What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? - correct answer Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a muscle relaxant. Benzotropine (Cogentin) and Trihexyphenidyl (Artane) are anticholinergic medications used for extrapyramidal side effects (EPS). Mr. Smith is a 56 ...
    (0)
  • $15.49
  • + learn more
ANCC Review Exam  2024/2025  Questions and  Answers (PMHNP IQ) with verified solutions
  • ANCC Review Exam 2024/2025 Questions and Answers (PMHNP IQ) with verified solutions

  • Exam (elaborations) • 19 pages • 2023
  • Available in package deal
  • ANCC Review Exam 2023/2024 Questions and Answers (PMHNP IQ) with verified solutions What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? A) benzotropine (Cogentin) B) bromocriptine (Parlodel) C) dantrolene (Dantrium) D) trihexyphenidyl (Artane) - A) Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Da...
    (0)
  • $12.49
  • + learn more
ANCC Review Exam 2023/2024 Questions and Answers (PMHNP IQ) with verified solutions
  • ANCC Review Exam 2023/2024 Questions and Answers (PMHNP IQ) with verified solutions

  • Exam (elaborations) • 19 pages • 2023
  • Available in package deal
  • What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? A) benzotropine (Cogentin) B) bromocriptine (Parlodel) C) dantrolene (Dantrium) D) trihexyphenidyl (Artane) - A) Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a muscle relaxant. Benzotropine (Cogentin) and Trihexyphenidyl (...
    (0)
  • $13.48
  • + learn more
ANCC Review Questions (PMHNP IQ) Questions with 100% Correct Answers | Latest Update | Verified
  • ANCC Review Questions (PMHNP IQ) Questions with 100% Correct Answers | Latest Update | Verified

  • Exam (elaborations) • 10 pages • 2023
  • Available in package deal
  • What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? A) benzotropine (Cogentin) B) bromocriptine (Parlodel) C) dantrolene (Dantrium) D) trihexyphenidyl (Artane) - A) Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a muscle relaxant. Benzotropine (Cogentin) and Trihexyphenidyl (Ar...
    (0)
  • $12.49
  • + learn more
ANCC Review Questions (PMHNP IQ) Correct 100%
  • ANCC Review Questions (PMHNP IQ) Correct 100%

  • Exam (elaborations) • 7 pages • 2023
  • Available in package deal
  • What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? A) benzotropine (Cogentin) B) bromocriptine (Parlodel) C) dantrolene (Dantrium) D) trihexyphenidyl (Artane) - ANSWER A) Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a muscle relaxant. Benzotropine (Cogentin) and Trihexyphenid...
    (0)
  • $11.99
  • + learn more
ANCC Review Questions (PMHNP IQ) (2023/2024) Already Graded A
  • ANCC Review Questions (PMHNP IQ) (2023/2024) Already Graded A

  • Exam (elaborations) • 16 pages • 2023
  • Available in package deal
  • ANCC Review Questions (PMHNP IQ) (2023/2024) Already Graded A What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? A) benzotropine (Cogentin) B) bromocriptine (Parlodel) C) dantrolene (Dantrium) D) trihexyphenidyl (Artane) A) Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a muscle ...
    (0)
  • $9.99
  • + learn more
ANCC Review Questions (PMHNP IQ) with correct Answers
  • ANCC Review Questions (PMHNP IQ) with correct Answers

  • Exam (elaborations) • 9 pages • 2024
  • Available in package deal
  • ANCC Review Questions (PMHNP IQ) with correct Answers What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? A) benzotropine (Cogentin) B) bromocriptine (Parlodel) C) dantrolene (Dantrium) D) trihexyphenidyl (Artane) - Answer ️️ -A) Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium)...
    (0)
  • $11.49
  • + learn more
ANCC Review Questions (PMHNP IQ)  | Question With 100% Correct Answers | Verified
  • ANCC Review Questions (PMHNP IQ) | Question With 100% Correct Answers | Verified

  • Exam (elaborations) • 10 pages • 2023
  • Available in package deal
  • What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? A) benzotropine (Cogentin) B) bromocriptine (Parlodel) C) dantrolene (Dantrium) D) trihexyphenidyl (Artane) - A) Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a muscle relaxant. Benzotropine (Cogentin) and Trihexyphenidyl (Ar...
    (0)
  • $7.99
  • + learn more
ANCC Review Questions (PMHNP IQ) Latest 2022/2023 Already Graded A
  • ANCC Review Questions (PMHNP IQ) Latest 2022/2023 Already Graded A

  • Exam (elaborations) • 10 pages • 2023
  • What direct-acting dopamine receptor agonist is recommended to be used in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade? A) benzotropine (Cogentin) B) bromocriptine (Parlodel) C) dantrolene (Dantrium) D) trihexyphenidyl (Artane) A) Bromocriptine (Parlodel) is the recommended direct acting dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a muscle relaxant. Benzotropine (Cogentin) and Trihexyphenidyl (Arta...
    (0)
  • $10.49
  • + learn more